In malignancy processes, it was noted that the activation of either NFKB1 or NFKB2 is associated with different phenotypes of cancer, namely in diffuse large B-cell lymphoma (DLBCL) [5]. Here, NFKB1 is linked to diffuse large B-cell lymphoma.